Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring?

References

• Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503–e551.
   PubMed Web of Science ®Google Scholar
• Virani SA, Sharma V, McCann M, et al., Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE-HF study. ESC Heart Fail. 2018;5(5):809–817.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Anker SD, AlHabib KF, et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1(1):4–25.
   PubMedGoogle Scholar
• Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–2150.
   PubMed Web of Science ®Google Scholar
• Boriani G, Berti E, Belotti LM, et al. Cardiac device therapy in patients with left ventricular dysfunction and heart failure: ‘real-world’ data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital). Eur J Heart Fail. 2016;18(6):693–702.
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–1549.
   PubMed Web of Science ®Google Scholar
• Varma N, Epstein AE, Irimpen A, et al., Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T safely reduces routine office device follow-up (TRUST) trial. Circulation. 2010;122(4):325–332.
   PubMed Web of Science ®Google Scholar
• Russo V, Rago A, Tavoletta V, et al. Remote monitoring of atrial high rate episodes in pacemaker patients. the rapid study design. J Atr Fibrillation. 2018;11(2):2075.
   PubMedGoogle Scholar
• Slotwiner D, Varma N, Akar JG, et al., HRS expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm. 2015;12(7):e69–100.
   PubMed Web of Science ®Google Scholar
• Varma N, Michalski J, Stambler B, et al., Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations. Eur Heart J. 2014;35(20):1345–1352.
   PubMed Web of Science ®Google Scholar
• Guédon-Moreau L, Lacroix D, Sadoul N, et al., A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J. 2013;34(8):605–614.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Taborsky M, Glikson M, et al., Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014;384(9943):583–590.
   PubMed Web of Science ®Google Scholar
• Boehmer JP, Hariharan R, Devecchi FG, et al., A multisensor algorithm predicts heart failure events in patients with implanted devices: results from the multisense study. JACC Heart Fail. 2017;5(3):216–225.
   PubMed Web of Science ®Google Scholar
• Capucci A, Santini L, Favale S, et al., Preliminary experience with the multisensor Heartlogic algorithm for heart failure monitoring: a retrospective case series report. ESC Heart Fail. 2019;6(2):308–318.
   PubMed Web of Science ®Google Scholar
• Watanabe E, Yamazaki F, Goto T, et al., Remote management of pacemaker patients with biennial in-clinic evaluation: continuous home monitoring in the Japanese at-home study: a randomized clinical trial. Circ Arrhythm Electrophysiol. 2020;13(5):e007734.
   PubMed Web of Science ®Google Scholar
• Boriani G, Da Costa A, Quesada A, et al., Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail. 2017;19(3):416–425.
   PubMed Web of Science ®Google Scholar
• Russo V, Nigro G, D’Onofrio A. COVID-19 and cardiac implantable electronic device remote monitoring:. Expert Rev Med Devices. 2020;17(6):471–472.
   PubMed Web of Science ®Google Scholar
• Palmisano P, Melissano D, Zanotto G, et al. Change in the use of remote monitoring of cardiac implantable electronic devices in Italian clinical practice over a 5-year period: results of two surveys promoted by the AIAC (Italian association of Arrhythmology and Cardiac Pacing). J Cardiovasc Med (Hagerstown). 2020;21(4):305–314.
   PubMed Web of Science ®Google Scholar
• Clarke M, Shah A, Sharma U. Systematic review of studies on telemonitoring of patients with congestive heart failure: a meta-analysis. J Telemed Telecare. 2011;17(1):7–14.
   PubMed Web of Science ®Google Scholar
• Gonseth J, Guallar-Castillón P, Banegas JR, et al. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J. 2004;25(18):1570–1595.
   PubMed Web of Science ®Google Scholar
• Roccaforte R, Demers C, Baldassarre F, et al. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail. 2005;7(7):1133–1144.
   PubMed Web of Science ®Google Scholar
• Gustafsson F, Arnold JM. Heart failure clinics and outpatient management: review of the evidence and call for quality assurance. Eur Heart J. 2004;25(18):1596–1604.
   PubMed Web of Science ®Google Scholar
• Whellan DJ, Hasselblad V, Peterson E, et al. Metaanalysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J. 2005;149(4):722–729.
   PubMed Web of Science ®Google Scholar
• Martínez A, Everss E, Rojo-Alvarez JL, et al. A systematic review of the literature on home monitoring for patients with heart failure. J Telemed Telecare. 2006;12(5):234–241.
   PubMed Web of Science ®Google Scholar
• Louis AA, Turner T, Gretton M, et al. A systematic review of telemonitoring for the management of heart failure. Eur J Heart Fail. 2003;5(5):583–590.
   PubMed Web of Science ®Google Scholar
• Clark RA, Inglis SC, McAlister FA, et al. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ. 2007;334(7600):942.
   PubMedGoogle Scholar
• Vollmann D, Nägele H, Schauerte P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. 2007;28(15):1835–1840.
   PubMed Web of Science ®Google Scholar
• Small RS, Wickemeyer W, Germany R, et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. 2009;15(6):475–481.
   PubMed Web of Science ®Google Scholar
• van Veldhuisen DJ, Braunschweig F, Conraads V, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011;124(16):1719–1726.
   PubMed Web of Science ®Google Scholar
• Whellan DJ, Ousdigian KT, Al-Khatib SM, et al., Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (program to access and review trending information and evaluate correlation to symptoms in patients with heart failure) study. J Am Coll Cardiol. 2010;55(17):1803–1810.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Sarkar S, Koehler J, et al., Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur Heart J. 2013;34(31):2472–2480.
   PubMed Web of Science ®Google Scholar
• Burri H, da Costa A, Quesada A, et al. Risk stratification of cardiovascular and heart failure hospitalizations using integrated device diagnostics in patients with a cardiac resynchronization therapy defibrillator. Europace. 2018;20(5):e69–e77.
   PubMed Web of Science ®Google Scholar
• Gula LJ, Wells GA, Yee R, et al., A novel algorithm to assess risk of heart failure exacerbation using ICD diagnostics: validation from RAFT. Heart Rhythm. 2014;11(9):1626–1631.
   PubMed Web of Science ®Google Scholar
• Ahmed FZ, Taylor JK, Green C, et al., Triage-HF plus: a novel device-based remote monitoring pathway to identify worsening heart failure. ESC Heart Fail. 2020;7(1):107–116.
   PubMed Web of Science ®Google Scholar
• D’Onofrio A, Solimene F, Calò L, et al. Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study. Europace. 2021. https://doi.org/10.1093/europace/euab170
   Google Scholar
• Calò L, Bianchi V, and Ferraioli D, et al. Multiparametric implantable cardioverter-defibrillator algorithm for heart failure risk stratification and management: an analysis in clinical practice. Circ Heart Fail. 2021;14(10):120008134.
   Web of Science ®Google Scholar
• Cowie MR, Anker SD, Cleland JGF, et al. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail. 2014;1(2):110–145.
   PubMedGoogle Scholar
• Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154(2):260–266.
   PubMed Web of Science ®Google Scholar
• TRIAGE-HF™ algorithm.[cited 2022 Jan 5]. Available from: https://www.medtronic.com/us-en/healthcare-professionals/therapies-procedures/cardiac-rhythm/cardiac-device-features/crt-features/triagehf.html
   Google Scholar
• MyMerlinPulse™ app. [Cited 2022 Jan 5]. Available from: https://www.cardiovascular.abbott/content/dam/bss/divisionalsites/cv/hcp/products/cardiac-rhythm-management/gallant-icd/documents/crm-clinician-remote-monitoring-guide-mymerlin.pdf
   Google Scholar
• MyLATITUDE™ app. [Cited 2022 Jan 5]. Available from: https://www.bostonscientific.com/content/dam/bostonscientific/Rhythm%20Management/portfolio-group/LATITUDE/CRM-623311-B_LAT_APP_Patient_brochure_Final.pdf
   Google Scholar
• BIOTRONIK Patient App™. [Cited 2022 Jan 5]. Available from: https://www.biotronik.com/en-de/patients/patientapp
   Google Scholar
• MyCareLink Heart™ app. [Cited 2022 Jan 5]. Available from: https://global.medtronic.com/xg-en/mobileapps/patient-caregiver/cardiac-monitoring/mycarelink-heart-app-it-IT.html
   Google Scholar
• MYTRIAGEHF™ app. [Cited 2022 Jan 5]. Available from: https://appadvice.com/app/mytriagehf/1534754611
   Google Scholar
• Boriani G, Maisano A, Bonini N, et al. Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: the INFO-COVID survey. J Geriatr Cardiol. 2021;18(9):739–747.
   PubMedGoogle Scholar
• Imberti JF, Tosetti A, and Mei DA, et al. Remote monitoring and telemedicine in heart failure: implementation and benefits. Curr Cardiol Rep. 2021;23(6):55.
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, and Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726.
   Web of Science ®Google Scholar